Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Glaxo Whistleblower: ‘The Worst Thing I Ever Saw’
Pharmalot
Monday, January 3, 2011 - 2:50pm
tags:
GSK, whistleblowers
Bioheart suspends clinical trial
Bizjournals.com
Monday, January 3, 2011 - 2:48pm
tags:
Bioheart
Repros shares slip despite trial news
Bizjournals.com
Monday, January 3, 2011 - 2:46pm
tags:
Repros Therapeutics, Androxal, testosterone
Biotech Busts And Breakthroughs In December
Forbes
Monday, January 3, 2011 - 2:44pm
tags:
biotech, InterMune, Orexigen, Exelixis, Dynavax, Sangamo BioSciences, Pain Therapeutics, Abiomed, Keryx, Geron, Clinical Data
Zogenix shares climb after stock rated 'Buy'
Yahoo/AP
Monday, January 3, 2011 - 2:42pm
tags:
migraines, Zogenix, Sumavel DosePro
China Biotech Week in Review: End of the Year Transactions
Seeking Alpha
Monday, January 3, 2011 - 2:38pm
tags:
China, biotech
Lupin Settles Lawsuit With Sunovion Over Copies of Lunesta Sleeping Pill
Bloomberg
Monday, January 3, 2011 - 12:21pm
tags:
insomnia, Lunesta, Sunovion, Lupin
Inspire Shares Tumble After Cystic Fibrosis Drug Fails in Advanced Testing
Bloomberg
Monday, January 3, 2011 - 12:16pm
tags:
Inspire, cystic fibrosis, denufosol
4-Star Stocks Poised to Pop: Merck
Motley Fool
Monday, January 3, 2011 - 12:08pm
tags:
Merck
J&J to Bring Cancer Test to Market
TheStreet.com
Monday, January 3, 2011 - 12:03pm
tags:
cancer, JNJ
Repros shares slip on final day of 2010 trading
bizjournals.com
Sunday, January 2, 2011 - 12:26pm
tags:
Repros Therapeutics, investors
Drug Stocks Ended Mostly Lower (King Pharmaceuticals, AMGN, ARNA, XOMA)
Wall Street Bay
Sunday, January 2, 2011 - 12:24pm
tags:
King, Amgen, Arena Pharmaceuticals, Xoma
Medicis Pharmaceutical: The Trend Continues Lower (MRX)
Benzinga
Sunday, January 2, 2011 - 12:21pm
tags:
Medicis, investors
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) Given “Neutral” Rating by Zacks Investment Research Analysts
American Banking News
Sunday, January 2, 2011 - 12:20pm
tags:
Questcor Pharmaceuticals, investors
Taj Pharmaceuticals bags US FDA approval for generic Topiramate Tablets
Market Press Release
Sunday, January 2, 2011 - 12:18pm
tags:
Taj Pharmaceuticals, Topiramate
Jiangbo Pharmaceuticals Inc (NASDAQ: JGBO) Posts Large Volume Increase, Hits $5.73
American Banking News
Sunday, January 2, 2011 - 12:16pm
tags:
Jiangbo Pharmaceuticals, investors
Nymox Pharmaceutical Climbs 6.9%
Benzinga
Sunday, January 2, 2011 - 12:15pm
tags:
Nymox, investors
Ista Pharmaceuticals Inc (NASDAQ: ISTA) Closes Above 200-Day Moving Average, Hits $5.22
American Banking News
Sunday, January 2, 2011 - 12:15pm
tags:
Ista, investors
Here's How ViroPharma May Be Failing You
Motley Fool
Sunday, January 2, 2011 - 12:13pm
tags:
ViroPharma, investors
Here's How ViroPharma Is Making You So Much Cash
Motley Fool
Sunday, January 2, 2011 - 12:12pm
tags:
ViroPharma, investors

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.